Bullish option flow detected in Viking Therapeutics (VKTX) with 7,276 calls trading, 1.4x expected, and implied vol increasing over 1 point to 94.78%. Jan-26 50 calls and Jan-26 60 calls are the most active options, with total volume in those strikes near 4,000 contracts. The Put/Call Ratio is 0.18. Earnings are expected on February 4th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Strong Enrollment and Promising Strategy Propel Viking Therapeutics to ‘Buy’ Rating
- Promising Potential of Viking Therapeutics’ VK2735 Justifies Buy Rating
- Viking Therapeutics completes patient enrollment in VANQUISH-1 clinical trial
- Viking Therapeutics price target raised to $107 from $106 at Canaccord
- Viking Therapeutics Stock (VKTX) Jumps on Obesity Drug. Next Big Pharma Target?